Safety Study of Hemospan® in Prostatectomy Patients
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This is a progressive dose escalation study designed to evaluate the safety of Hemospan
compared to a standard crystalloid solution (Ringer's lactate) in elective surgery patients
undergoing total prostatectomy procedures with anticipated blood loss of more than 500 mL.
Secondary objectives of this study are to observe possible activity of Hemospan for tissue
oxygenation, perfusion and cardiovascular support.